Medicines, 2017
Shortlist up to four to read them side by side.
1,073 medicine recalls FDA’s Enforcement Report published in 2017, newest first; 18,075 in all since 2012.
FDA’s medicine recalls, as its Enforcement Report classifies them, from June 2012. Lists of FDA’s records can’t be saved for alerts: openFDA asks that its data not be used to alert the public (openFDA); FDA’s own emails do that. Copied Nov 5, 2026.
1,073of 1,073 medicine recallsshown with your filters
The list
- Medicine recall ZRECT Male Enhancement Herbal Dietary Supplement Capsules, 500 mg, supplied Marketed without an Approved NDA/ANDA; FDA analysis found the presence of undeclared tadalafil, sildenafil and/or their analogues and Flibanserin FDA Class I, its most serious class Class IFDA’s class (needs attention)Jul 19, 2017in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJul 19, 2017ClassClass IStatusTerminatedWhereNationwide
- Medicine recall Xrect Male Enhancement Herbal Dietary Supplement Capsules, 500 mg supplied Marketed without an Approved NDA/ANDA; FDA analysis found the presence of undeclared tadalafil, sildenafil and/or their analogues and Flibanserin FDA Class I, its most serious class Class IFDA’s class (needs attention)Jul 19, 2017in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJul 19, 2017ClassClass IStatusTerminatedWhereNationwide
- Medicine recall RECTALIS Male Enhancement Herbal Dietary Supplement Capsules, 500 mg, supplied Marketed without an Approved NDA/ANDA; FDA analysis found the presence of undeclared tadalafil, sildenafil and/or their analogues and Flibanserin FDA Class I, its most serious class Class IFDA’s class (needs attention)Jul 19, 2017in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJul 19, 2017ClassClass IStatusTerminatedWhereNationwide
- Medicine recall TORNADO Male Enhancement Herbal Dietary Supplement Capsules, Over 4000 mg value, supplied Marketed without an Approved NDA/ANDA; FDA analysis found the presence of undeclared tadalafil, sildenafil and/or their analogues and Flibanserin FDA Class I, its most serious class Class IFDA’s class (needs attention)Jul 19, 2017in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJul 19, 2017ClassClass IStatusTerminatedWhereNationwide
- Medicine recall ZDaily Daily Testosterone and Llibido Booster Herbal Dietary Supplement Capsules, 500 mg, supplied Marketed without an Approved NDA/ANDA; FDA analysis found the presence of undeclared tadalafil, sildenafil and/or their analogues and Flibanserin FDA Class I, its most serious class Class IFDA’s class (needs attention)Jul 19, 2017in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJul 19, 2017ClassClass IStatusTerminatedWhereNationwide
- Medicine recall BIGnHARD Male Enhancement Herbal Dietary Supplement Capsules, 500 mg, supplied Marketed without an Approved NDA/ANDA; FDA analysis found the presence of undeclared tadalafil, sildenafil and/or their analogues and Flibanserin FDA Class I, its most serious class Class IFDA’s class (needs attention)Jul 19, 2017in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJul 19, 2017ClassClass IStatusTerminatedWhereNationwide
- Medicine recall ENHANCEROL Herbal Dietary Supplement Capsules, 500 mg, supplied Marketed without an Approved NDA/ANDA; FDA analysis found the presence of undeclared tadalafil, sildenafil and/or their analogues and Flibanserin FDA Class I, its most serious class Class IFDA’s class (needs attention)Jul 19, 2017in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJul 19, 2017ClassClass IStatusTerminatedWhereNationwide
- Medicine recall ZRECT for Women Herbal Dietary Supplement Capsules, 500 mg, supplied Marketed without an Approved NDA/ANDA; FDA analysis found the presence of undeclared tadalafil, sildenafil and/or their analogues and Flibanserin FDA Class I, its most serious class Class IFDA’s class (needs attention)Jul 19, 2017in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJul 19, 2017ClassClass IStatusTerminatedWhereNationwide
- Medicine recall LabidaMAX Herbal Dietary Supplement Capsules, 500 mg, supplied Marketed without an Approved NDA/ANDA; FDA analysis found the presence of undeclared tadalafil, sildenafil and/or their analogues and Flibanserin FDA Class I, its most serious class Class IFDA’s class (needs attention)Jul 19, 2017in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJul 19, 2017ClassClass IStatusTerminatedWhereNationwide
- Medicine recall 5% Dextrose Injection, USP, 100 mL VIAFLEX Plastic Container Lack of Assurance of Sterility: Bags have the potential to leak. Class IIFDA’s classJul 19, 2017in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedJul 19, 2017ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall 0.9% Sodium Chloride Injection, USP, 100 mL VIAFLEX Container Lack of Assurance of Sterility: Bags have the potential to leak. Class IIFDA’s classJul 19, 2017in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedJul 19, 2017ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Paroxetine Extended-Release Tablets USP, 12.5 mg, 30 count bottle Failed Dissolution Specifications: out of specification observed in dissolution testing at 3 month long term stability study. Class IIIFDA’s classJul 19, 2017in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJul 19, 2017ClassClass IIIStatusTerminatedWhereNationwide
- Medicine recall CVS Health Baby Eczema Moisturizing Cream(colloidal oatmeal 1.0%) Microbial Contamination of Non Sterile Products; out of specification Total Plate Count Class IIFDA’s classJul 19, 2017in FDA’s Enforcement ReportCaliforniathe one state its words name PublishedJul 19, 2017ClassClass IIStatusTerminatedWhereCalifornia
- Medicine recall Potassium PHOSphate added to 250 mL 0.9% Sodium Chloride 10 mMol Lack of sterility assurance Class IIFDA’s classJul 19, 2017in FDA’s Enforcement Report4 statesnamed in where it went PublishedJul 19, 2017ClassClass IIStatusTerminatedWhereLouisiana, New York, Pennsylvania and Wisconsin
- Medicine recall Potassium PHOSphate added to 250 mL 0.9% Sodium Chloride 15 mMol Lack of sterility assurance Class IIFDA’s classJul 19, 2017in FDA’s Enforcement Report4 statesnamed in where it went PublishedJul 19, 2017ClassClass IIStatusTerminatedWhereLouisiana, New York, Pennsylvania and Wisconsin
- Medicine recall Potassium PHOSphate added to 250 mL 0.9% Sodium Chloride 15 mMol Lack of sterility assurance Class IIFDA’s classJul 19, 2017in FDA’s Enforcement Report4 statesnamed in where it went PublishedJul 19, 2017ClassClass IIStatusTerminatedWhereLouisiana, New York, Pennsylvania and Wisconsin
- Medicine recall Potassium PHOSphate added to 0.9% Sodium Chloride 250 mL Bag 30 mMol Lack of sterility assurance Class IIFDA’s classJul 19, 2017in FDA’s Enforcement Report4 statesnamed in where it went PublishedJul 19, 2017ClassClass IIStatusTerminatedWhereLouisiana, New York, Pennsylvania and Wisconsin
- Medicine recall Ropivacaine HCl 0.2% 400 mL Total Volume in an ON-Q Pump Labeling: Incorrect or Missing Lot and/or Exp Date Class IIIFDA’s classJul 12, 2017in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJul 12, 2017ClassClass IIIStatusTerminatedWhereNationwide
- Medicine recall Ropivacaine HCl 0.2% 500 mL Total Volume in an ON-Q Pump Labeling: Incorrect or Missing Lot and/or Exp Date Class IIIFDA’s classJul 12, 2017in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJul 12, 2017ClassClass IIIStatusTerminatedWhereNationwide
- Medicine recall Ropivacaine HCl 0.2% 500 mL Total Volume in an ON-Q Pump Labeling: Incorrect or Missing Lot and/or Exp Date Class IIIFDA’s classJul 12, 2017in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJul 12, 2017ClassClass IIIStatusTerminatedWhereNationwide
- Medicine recall Ropivacaine HCl 0.2% 750 mL Total Volume in an ON-Q Pump Labeling: Incorrect or Missing Lot and/or Exp Date Class IIIFDA’s classJul 12, 2017in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJul 12, 2017ClassClass IIIStatusTerminatedWhereNationwide
- Medicine recall Ropivacaine HCl 0.2% 550 mL Total Volume in an AutoFuser Pump Labeling: Incorrect or Missing Lot and/or Exp Date Class IIIFDA’s classJul 12, 2017in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJul 12, 2017ClassClass IIIStatusTerminatedWhereNationwide
- Medicine recall Bupivacaine HCl 0.25% 270 mL Total Volume in an ON-Q Pump Labeling: Incorrect or Missing Lot and/or Exp Date Class IIIFDA’s classJul 12, 2017in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJul 12, 2017ClassClass IIIStatusTerminatedWhereNationwide
- Medicine recall Bupivacaine HCl 0.25% 400 mL Total Volume in an ON-Q Pump Labeling: Incorrect or Missing Lot and/or Exp Date Class IIIFDA’s classJul 12, 2017in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJul 12, 2017ClassClass IIIStatusTerminatedWhereNationwide
- Medicine recall Methocarbamol, USP CGMP Deviations: Lack of quality assurance at the API manufacturer. Class IIFDA’s classJul 12, 2017in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJul 12, 2017ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Chlorhexidine Gluconate 0.12% Oral Rinse, USP, 1 Pint CGMP Deviations Class IIFDA’s classJul 12, 2017in FDA’s Enforcement ReportNot namedno state, in where it went PublishedJul 12, 2017ClassClass IIStatusTerminatedWhereNo state named
- Medicine recall Clindamycin Injection USP Lack of Assurance of Sterility Class IIFDA’s classJul 12, 2017in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJul 12, 2017ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Clindamycin Injection USP Lack of Assurance of Sterility Class IIFDA’s classJul 12, 2017in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJul 12, 2017ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Clindamycin Injection USP Lack of Assurance of Sterility Class IIFDA’s classJul 12, 2017in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJul 12, 2017ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Fludeoxyglucose F 18 Injection, 20mCi/mL to 200 mCi/mL at EOS, 30 mL Multiple-Dose Vial Failed Impurities/Degradation Specifications; out of specification result for Acetonitrile residual solvent Class IIIFDA’s classJul 12, 2017in FDA’s Enforcement ReportPuerto Ricothe one state its words name PublishedJul 12, 2017ClassClass IIIStatusTerminatedWherePuerto Rico
- Medicine recall Amitriptyline HCl Tablets, USP 25 mg Cross Contamination With Other Product: Imipramine Class IIIFDA’s classJul 12, 2017in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJul 12, 2017ClassClass IIIStatusTerminatedWhereNationwide
- Medicine recall parodontax WHITENING (Stannous fluoride) Daily Fluoride Anticavity and Antigingivitis Toothpaste, 0.454% Presence of Foreign Substance: possibility of the presence of metal in the product. Class IIFDA’s classJul 12, 2017in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJul 12, 2017ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall G & W Clobetasol Propionate Ointment 0.05% Failed impurities/degradation specifications: This product is being recalled due to out of specification results for Clobetasol Related Compound A, a known… Class IIIFDA’s classJul 12, 2017in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJul 12, 2017ClassClass IIIStatusTerminatedWhereNationwide
- Medicine recall Succinylcholine Chloride, 100 mg per 5mL, 20 mg per mL syringe Lack Of Assurance Of Sterility: voluntary recall initiated by the commercial supplier Class IIFDA’s classJul 12, 2017in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJul 12, 2017ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Tetracycline-ABC Brand Topical ointment First Aid Antibiotic, tetracycline GMP Deviations; FDA inspection found significant manufacturing practices that call into question the safety, identity, strength, quality and purity of… Class IIFDA’s classJul 12, 2017in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJul 12, 2017ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall TetraStem brand Topical Ointment First Aid Antibiotic, tetracycline GMP Deviations; FDA inspection found significant manufacturing practices that call into question the safety, identity, strength, quality and purity of… Class IIFDA’s classJul 12, 2017in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJul 12, 2017ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Diabecline brand Topical Ointment First Aid Antibiotic, tetracycline GMP Deviations; FDA inspection found significant manufacturing practices that call into question the safety, identity, strength, quality and purity of… Class IIFDA’s classJul 12, 2017in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJul 12, 2017ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall StingMed Insect bites Skin Protectant GMP Deviations; FDA inspection found significant manufacturing practices that call into question the safety, identity, strength, quality and purity of… Class IIFDA’s classJul 12, 2017in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJul 12, 2017ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall StaphWash+Plus+ Skin Protectant, Zinc acetate (.1% by volume), 0.3 fl GMP Deviations; FDA inspection found significant manufacturing practices that call into question the safety, identity, strength, quality and purity of… Class IIFDA’s classJul 12, 2017in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJul 12, 2017ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall VenomX, Zinc acetate (.1% by volume), 0.3 fl GMP Deviations; FDA inspection found significant manufacturing practices that call into question the safety, identity, strength, quality and purity of… Class IIFDA’s classJul 12, 2017in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJul 12, 2017ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Minivelle (estradiol Transdermal System) 0.1 mg per day, pack of 8 systems per carton Defective Delivery System: Out of specification for peel force from the release liner specification during stability testing at 18M 25C/60%RH. Class IIIFDA’s classJul 5, 2017in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJul 5, 2017ClassClass IIIStatusTerminatedWhereNationwide
- Medicine recall Progesterone Injection in Olive Oil With Benzyl Alcohol 10%, 50mg/mL, 10mL Multi-Dose Vial Lack of Processing Controls: The metal container closure adheres to the rubber stopper on some of the units of the batch which can impact the integrity of the… Class IIFDA’s classJul 5, 2017in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJul 5, 2017ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Walgreens Daytime and Nighttime Cold & Flu Labeling: Label Mix-Up - This product is being recalled due to an incorrect product sleeve on the product twin pack. Class IIIFDA’s classJul 5, 2017in FDA’s Enforcement ReportIllinoisthe one state its words name PublishedJul 5, 2017ClassClass IIIStatusTerminatedWhereIllinois
- Medicine recall Gaviscon (Alumina & Magnesium Trisilicate) Regular Strength Original Flavor Chewable Tablets, 80 mg & 14.2… Superpotent Drug: high out-of-specification result for magnesium. Class IIIFDA’s classJul 5, 2017in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedJul 5, 2017ClassClass IIIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Doxycycline Hyclate USP, active pharmaceutical ingredient, a) 25 g Labeling: Not Elsewhere Classified. Class IIFDA’s classJul 5, 2017in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJul 5, 2017ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall BuPROPion HCL Tablets, USP, 75 mg Failed Moisture Limits: Product tested out-of-specification for moisture content. Class IIIFDA’s classJul 5, 2017in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJul 5, 2017ClassClass IIIStatusTerminatedWhereNationwide
- Medicine recall Blephamide (sulfacetamide sodium and prednisolone acetate ophthalmic ointment, USP) 10%/0.2% sterile, 3.5 g… Failed Impurities/Degradation Specifications: stability testing results did not meet the specification for impurities. Class IIFDA’s classJul 5, 2017in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJul 5, 2017ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Venlafaxine Hydrochloride Extended-Release Capsules USP, 75 mg Failed Tablet/Capsules Specifications: pharmacists complaints for bottles containing melted capsules. Class IIFDA’s classJun 28, 2017in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJun 28, 2017ClassClass IIStatusTerminatedWhereNationwide
Nothing matches all of these.
Remove a filter to see more. Each one is a fact FDA’s record publishes, so a recall can be left out because its record is silent on it.
Source:
FDA, Drug recall enforcement reports. Released Nov 3, 2026. Updated weekly.
Recalls of food, medicines, medical devices, pet food and animal drugs are from the U.S. Food and Drug Administration (FDA). FDA does not endorse Hearth Record. openFDA: “Do not rely on openFDA to make decisions regarding medical care.”
Your shortlist0 of 4
Add one more to compare.